• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Brief Outpatient Rehab Program Beneficial for Post-COVID-19 Condition

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 26, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, Dec. 26, 2024 -- A brief outpatient rehabilitation program with a cognitive and behavioral approach is effective and safe for patients with post-COVID-19 condition (PCC), according to a study published online Dec. 19 in JAMA Network Open.

Tom Farmen Nerli, M.D., from Akershus University Hospital in Lørenskog, Norway, and colleagues examined the effectiveness of a brief outpatient rehabilitation program based on a cognitive and behavioral approach in a randomized trial involving patients with mild-to-moderate PCC. Participants were randomly assigned to an established transdiagnostic rehabilitation program, which consisted of two to eight outpatient encounters with about two to six weeks between each encounter, or care as usual.

A total of 314 patients were included in the study and 231 completed the primary end point evaluation. The researchers found statistically and clinically significant improvement in the Short-Form Health Survey 36 Physical Function Subscale scores (score difference between groups, 9.2). Over time, the effect was sustained. The intervention was favored in most secondary and safety outcomes.

"In this randomized clinical trial of patients with PCC, a brief outpatient rehabilitation program with a cognitive and behavioral approach was effective and safe," the authors write. "This trial adds to the evidence supporting such interventions in routine clinical care."

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted December 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.